TECX — Tectonic Therapeutic Share News
0.000.00%
- $412.30m
- $185.41m
Avrobio rises on plans to explore strategic alternatives, job cuts
Brief: AVROBIO To Explore Strategic Alternatives
Brief: Avrobio Determines No Material Charges Expected To Incur With Cystinosis Gene Therapy Program Sale
Brief: Avrobio Receives Notice From Nasdaq On Non-Regained Compliance With Minimum Bid Price Requirement
Brief: Avrobio Completes Sale Of Cystinosis Gene Therapy Program For $87.5 Million
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill
Avrobio jumps on sale of gene therapy rights to Novartis
Brief: Avrobio Announces Agreement To Sell gene therapy program to Novartis For $87.5 Million
Avrobio jumps on gene therapy program sale to Novartis
U.S. STOCKS ON THE MOVE-Brady, Madison Square Garden Entertainment, Bowlero
U.S. STOCKS ON THE MOVE-Hawkins, Netflix, Alibaba Group
U.S. STOCKS ON THE MOVE-Dole, Canada Goose, Regency Centers
AVROBIO rises on positive data from investigational gene therapy trial
Brief: Avrobio Announces Positive Data From Phase 1/2 Clinical Trial Of Investigational Gene Therapy
Brief: Avrobio Reports Q1 2023 Financial Results And Provides Business Update
Avrobio Inc Reports Results For The Quarter Ended In March: Earnings Summary
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini